T. Rowe Price Investment Management’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,481,222
| Closed | -$50.3M | – | 635 |
|
|
2024
Q2 | $50.3M | Buy |
3,481,222
+419,518
| +14% | +$6.07M | 0.03% | 386 |
|
|
2024
Q1 | $50.9M | Buy |
3,061,704
+1,607,914
| +111% | +$26.7M | 0.03% | 392 |
|
|
2023
Q4 | $23.3M | Buy |
1,453,790
+21,822
| +2% | +$350K | 0.02% | 471 |
|
|
2023
Q3 | $19.3M | Buy |
1,431,968
+7,033
| +0.5% | +$94.6K | 0.01% | 478 |
|
|
2023
Q2 | $24.5M | Buy |
1,424,935
+213,443
| +18% | +$3.67M | 0.02% | 462 |
|
|
2023
Q1 | $20M | Buy |
1,211,492
+170
| +0% | +$2.81K | 0.01% | 473 |
|
|
2022
Q4 | $20.3M | Buy |
1,211,322
+111,322
| +10% | +$1.86M | 0.02% | 458 |
|
|
2022
Q3 | $18.8M | Buy |
+1,100,000
| New | +$18.8M | 0.02% | 456 |
|